STOCK TITAN

InspireMD to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

InspireMD (Nasdaq: NSPR) will participate in a fireside discussion at the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3, 2025 at 12:30 PM ET. The company, developer of the CGuard Prime carotid stent system, said a live audio webcast and a replay will be available on its Investor Calendar page. Investors can access the event via the provided webcast link and listen live or via the replay on the company website.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction

-2.04%
5 alerts
-2.04% News Effect
-17.6% Trough in 30 hr 10 min
-$2M Valuation Impact
$87M Market Cap
0.5x Rel. Volume

On the day this news was published, NSPR declined 2.04%, reflecting a moderate negative market reaction. Argus tracked a trough of -17.6% from its starting point during tracking. Our momentum scanner triggered 5 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $2M from the company's valuation, bringing the market cap to $87M at that time.

Data tracked by StockTitan Argus on the day of publication.

MIAMI, Nov. 19, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced plans to participate in a fireside discussion at the upcoming Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3rd at 12:30 pm Eastern Time (ET).

A live audio webcast and replay of the discussion may be accessed on the “Investor Calendar” section of the company’s website at: https://event.webcasts.com/starthere.jsp?ei=1744172&tp_key=a1a6262ba9

About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet™ mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on our website. For more information, please visit www.inspiremd.com.

Investor Contacts:
Webb Campbell
Gilmartin Group LLC
webb@gilmartinir.com
investor-relations@inspiremd.com


FAQ

When will InspireMD (NSPR) speak at the Piper Sandler 37th Annual Healthcare Conference?

InspireMD will speak on Wednesday, December 3, 2025 at 12:30 PM ET.

How can investors access the InspireMD (NSPR) webcast for the Piper Sandler conference?

Investors can access the live audio webcast and replay via the company’s Investor Calendar webpage using the provided webcast link.

Will there be a replay of the InspireMD (NSPR) fireside discussion on December 3, 2025?

Yes. A replay of the audio discussion will be available on the company’s Investor Calendar page.

What product will InspireMD (NSPR) highlight at the Piper Sandler conference?

The company is the developer of the CGuard Prime carotid stent system, which is noted in the event announcement.

Where is the InspireMD (NSPR) webcast hosted for the December 3, 2025 presentation?

The webcast is hosted via the link listed on InspireMD’s Investor Calendar and accessed through the company’s website.
Inspiremd

NASDAQ:NSPR

NSPR Rankings

NSPR Latest News

NSPR Latest SEC Filings

NSPR Stock Data

68.64M
30.47M
22.45%
40.55%
0.31%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
MIAMI